InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,522.30
(
1.58%
)
US TECH 100
18,928.80
(
3.43%
)
Dow Jones
40,842.79
(
0.24%
)
Brent Oil
81.51
(
3.75%
)
Bitcoin
64,960.33
(
-1.83%
)
Post# of 252757
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120171
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 202961

Friday, 07/29/2016 9:33:15 AM

Friday, July 29, 2016 9:33:15 AM

Post# of 252757

…is [now] a good time to invest in MNTA?

Yes, IMO. MNTA’s generic version of 40mg Copaxone has an FDA decision (BsUFA) date during 2H16, and I expect FDA approval on the first review cycle because the 40mg product is essentially the same as MNTA’s generic version of 20mg Copaxone.

40mg Copaxone has about 80% of the combined 20mg/40mg US Copaxone market; FDA approval of the 40mg generic will make MNTA cash-flow positive again.

For additional info, please see #msg-123678816.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up